Search hospitals > Missouri > Rolla

Delbert Day Cancer Institute at PCRMC

Claim this profile
Rolla, Missouri 65401
Global Leader in Skin Cancer
Global Leader in Stomach Cancer
Conducts research for Breast Cancer
Conducts research for Lung Cancer
Conducts research for Cancer
264 reported clinical trials
1 medical researcher
Photo of Delbert Day Cancer Institute at PCRMC in RollaPhoto of Delbert Day Cancer Institute at PCRMC in RollaPhoto of Delbert Day Cancer Institute at PCRMC in Rolla

Summary

Delbert Day Cancer Institute at PCRMC is a medical facility located in Rolla, Missouri. This center is recognized for care of Skin Cancer, Stomach Cancer, Breast Cancer, Lung Cancer, Cancer and other specialties. Delbert Day Cancer Institute at PCRMC is involved with conducting 264 clinical trials across 431 conditions. There are 1 research doctors associated with this hospital, such as Jay W Carlson.

Area of expertise

1Skin Cancer
Global Leader
Delbert Day Cancer Institute at PCRMC has run 115 trials for Skin Cancer. Some of their research focus areas include:
Stage IV
Stage III
Stage II
2Stomach Cancer
Global Leader
Delbert Day Cancer Institute at PCRMC has run 43 trials for Stomach Cancer. Some of their research focus areas include:
Stage IV
Stage III
Stage II

Top PIs

Clinical Trials running at Delbert Day Cancer Institute at PCRMC

Breast Cancer
Skin Cancer
Bladder Cancer
Lung Cancer
Prostate Cancer
Breast cancer
Non-Small Cell Lung Cancer
Stomach Cancer
Multiple Myeloma
Bladder Carcinoma
Image of trial facility.

Chemotherapy + Hormone Therapy

for Breast Cancer

This trial is testing if adding additional cancer-fighting drugs to treatments that stop certain body functions is better than just using the treatments that stop those functions alone. It targets younger women with early-stage breast cancer who have a higher risk of dying from the disease. The treatment works by stopping certain body functions and using drugs to kill cancer cells.
Recruiting2 awards Phase 319 criteria
Image of trial facility.

Shorter Chemo-Immunotherapy Without Anthracyclines

for Breast Cancer

This phase III trial compares the effects of shorter chemotherapy (chemo)-immunotherapy without anthracyclines to usual chemo-immunotherapy for the treatment of early-stage triple negative breast cancer. Paclitaxel is in a class of medications called anti-microtubule agents. It stops cancer cells from growing and dividing and may kill them. Carboplatin is in a class of medications known as platinum-containing compounds. It works in a way similar to the anticancer drug cisplatin, but may be better tolerated than cisplatin. Carboplatin works by killing, stopping or slowing the growth of cancer cells. Cyclophosphamide is in a class of medications called alkylating agents. It works by damaging the cell's deoxyribonucleic acid (DNA) and may kill cancer cells. It may also lower the body's immune response. Docetaxel is in a class of medications called taxanes. It stops cancer cells from growing and dividing and may kill them. Doxorubicin is an anthracycline chemotherapy drug that damages DNA and may kill cancer cells. Pembrolizumab may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Shorter treatment without anthracycline chemotherapy may work the same as the usual anthracycline chemotherapy treatment for early-stage triple negative breast cancer.
Recruiting2 awards Phase 347 criteria
Image of trial facility.

Support Program

for Breast Cancer

This phase III trial compares an additional support program (text message reminders and/or telephone-based counseling) with usual care in making sure breast cancer patients take their endocrine therapy medication as prescribed (medication adherence). Medication adherence is how well patients take the medication as prescribed by their doctors, and good medical adherence is when patients take medications correctly. Poor medication adherence has been shown to be a serious barrier to effective treatment for hormone receptor positive breast cancer patients. Adding text message reminders and/or telephone-based counseling to usual care may increase the number of days that patients take their endocrine therapy medication as prescribed.
Recruiting2 awards Phase 34 criteria

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at Delbert Day Cancer Institute at PCRMC?
Delbert Day Cancer Institute at PCRMC is a medical facility located in Rolla, Missouri. This center is recognized for care of Skin Cancer, Stomach Cancer, Breast Cancer, Lung Cancer, Cancer and other specialties. Delbert Day Cancer Institute at PCRMC is involved with conducting 264 clinical trials across 431 conditions. There are 1 research doctors associated with this hospital, such as Jay W Carlson.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security